Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
In animal models of transected sciatic nerve, BPC-157 improved axonal regeneration, increased the density and size of regenerative fibers, enhanced myelination, and restored motor function measured by electromyography and walking scores
Research shows that low serum vitamin B-12 levels are linked to decreased bone density, which can lead to fragile bones and a higher risk of osteoporosis
Concentration accuracy at the 0.9% level requires pharmaceutical-grade manufacturing controls that a standard lab cannot replicate reliably
In April 2026, the FDA removed BPC-157 from its Category 2 list (substances with safety concerns that were previously restricted from compounding)
Common "Glutathione Drainers" include: Environmental Toxins: Pollution, household chemicals, and heavy metals increase the demand for glutathione in the liver
The peptide's status as a naturally occurring tripeptide makes patent protection difficult, which removes the financial incentive for the multi-hundred-million-dollar investment that FDA approval requires
US$ 29.24
US$ 29.62
US$ 21.63
